• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

Ketamine more cost-effective than ECT for treatment-resistant depression

Psychiatric News | J Fontan/Getty/iStock
Psychiatric News | J Fontan/Getty/iStock

While ECT is a highly effective intervention for treatment-resistant depression, utilization is low in part because of patient concerns about adverse cognitive effects as well as the resources required (for example, needing a psychiatrist and anesthesiologist for each procedure). Relatedly, the short-term efficacy of ketamine for treatment-resistant depression has been well established, but there have been no longer-term studies assessing both its effectiveness and cost.

Posted in: News on 10/24/2026 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2026 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice